Disperazol Pharma ApS — Credit Rating and Financial Key Figures
CVR number: 44265761
Boserupvej 206, 3050 Humlebæk
mgivskov@sund.ku.dk
tel: 21409867
disperazol.dk
Income statement (kDKK)
2024 | |
|---|---|
| Fiscal period length | 12 |
| Net sales | |
| Gross profit | 40.50 |
| EBIT | 40.50 |
| Other financial income | 0.27 |
| Other financial expenses | -0.21 |
| Pre-tax profit | 40.55 |
| Income taxes | -8.93 |
| Net earnings | 31.62 |
Assets (kDKK)
2024 | |
|---|---|
| Intangible assets total | |
| Tangible assets total | |
| Investments total | |
| Long term receivables total | |
| Inventories total | |
| Short term receivables total | |
| Cash and bank deposits | 80.55 |
| Cash and cash equivalents | 80.55 |
| Balance sheet total (assets) | 80.55 |
Equity and liabilities (kDKK)
2024 | |
|---|---|
| Share capital | 40.00 |
| Profit of the financial year | 31.62 |
| Shareholders equity total | 71.62 |
| Non-current liabilities total | |
| Short-term deferred tax liabilities | 8.93 |
| Current liabilities total | 8.93 |
| Balance sheet total (liabilities) | 80.55 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.